Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 209-506-8 | CAS number: 583-52-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vitro
Administrative data
- Endpoint:
- in vitro cytogenicity / chromosome aberration study in mammalian cells
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- other:
- Remarks:
- The study is performed in line with OECD guideline 473 (in vitro mammalian chromosomal aberration test), materials and methods are well described. A deviation from this guideline is that the test is only performed without metabolic activation. Additionally, there are no detailed information on the results.
Data source
Reference
- Reference Type:
- publication
- Title:
- Primary mutagenicity screening of food additives
- Author:
- Ishidate Jr., M. Sofuni, T., Yoshikawa, K., Hayashi, M., Nohmi, T., Sawada, M., Matsuoka, A.
- Year:
- 1 984
- Bibliographic source:
- Food Chemistry and Toxicology, Vol. 22, No. 8, p 623-636
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 473 (In Vitro Mammalian Chromosomal Aberration Test)
- Version / remarks:
- Tested without metabolic activation
- Principles of method if other than guideline:
- - Principle of test:
Chromosomal aberration tests were carried out using a Chinese hamster fibroblast cell line, CHL.The cells were exposed to each sample at three different doses for 24 and 48 hr. A hundred well-spread metaphases were observed under the microscope (x 600 with a no- cover objective lens).
- Short description of test conditions: The modal chromosome number is 25 and the doubling time was approximately 15 hr. The cells were exposed to each sample at three different doses for 24 and 48 hr. In the present studies, no metabolic activation systems were applied. The maximum dose of each sample was selected by a preliminary test in which the dose needed for 50% cell-growth inhibition was estimated using a cell densitometer (Monocellater, Olympus Co., Ltd). Chromosome preparations were made as follows. Colcemid (final concn 0.2µg/mL) was added to the culture 2 hr before cell harvesting. The cells were then trypsinized and suspended in a hypotonic KCI solution (0.075 M) for 13 min at room temperature. After centrifugation the cells were fixed with acetic acid-methanol (1:3, v/v) and spread on clean glass slides. After air-drying, the slides were stained with Giemsa solution (1.5%, at pH 6.8; E. Merck) for 12-15 min. A hundred well-spread metaphases were observed under the microscope (x 600 with a no- cover objective lens).
- Parameters analysed / observed: The incidence of polyploid cells as well as of cells with structural chromosomal aberrations such as chromatid or chromosome gaps, breaks, exchanges, ring formations, fragmentations and others, was recorded on each culture plate. The results were considered to be negative if the incidence was less than 4.9%, equivocal if it was between 5.0 and 9.9%, and positive if it was more than 10.0%. For a quantitative evaluation of the clastogenic potential of the positive samples, the D20 was calculated, which is the dose (mg/mL) at which structural aberrations (including gaps) were detected in 20% of the metaphases observed. In addition, the TR value was calculated, which indicates the frequency of cells with exchange-type aberrations per unit dose (mg/mL). - GLP compliance:
- not specified
- Type of assay:
- in vitro mammalian chromosome aberration test
Test material
- Reference substance name:
- ethandioic acid
- Cas Number:
- 144-62-7
- Molecular formula:
- C2H2O4
- IUPAC Name:
- ethandioic acid
- Test material form:
- not specified
Constituent 1
Method
Species / strain
- Species / strain / cell type:
- Chinese hamster lung fibroblasts (V79)
- Details on mammalian cell type (if applicable):
- CELLS USED
- Type and source of cells: Chinese hamster lung fibroblasts (V79)
- Suitability of cells:
For cell lines:
- Number of passages if applicable: n/a
- Methods for maintenance in cell culture: The cells had been maintained by 4-day passages and grown in a monolayer in petri dishes with Eagle's MEM (GIBCO) supplemented with 10% calf serum.
- Cell cycle length, doubling time or proliferation index : doubling time approximately 15 h
- Modal number of chromosomes: 25
MEDIA USED
- Type and composition of media, CO2 concentration, humidity level, temperature, if applicable: Eagle's MEM (GIBCO) supplemented with 10% calf serum, other conditions not reported.
- Metabolic activation:
- without
- Test concentrations with justification for top dose:
- Three different doses were tested. The maximum dose (0.125 mg/mL) was determined by a preliminary test in which the dose needed for 50% cell-growth inhibition was estimated.
- Vehicle / solvent:
- - Vehicle(s)/solvent(s) used: physiol. saline
- Justification for choice of solvent/vehicle: not reported
Controls
- Untreated negative controls:
- yes
- Negative solvent / vehicle controls:
- yes
- True negative controls:
- no
- Positive controls:
- not specified
- Remarks:
- Incidence of aberrations in the negative control < 3%
- Details on test system and experimental conditions:
- NUMBER OF REPLICATIONS:
- Number of cultures per concentration: The cells were exposed to each sample at three different doses for 24 and 48 hr.
- Number of independent experiments : not reported
TREATMENT AND HARVEST SCHEDULE:
- Exposure duration/duration of treatment: 24 and 48h
FOR CHROMOSOME ABERRATION AND MICRONUCLEUS:
- Spindle inhibitor (cytogenetic assays): Colcemid; 0.2 µg/mL
- Methods of slide preparation and staining technique used including the stain used (for cytogenetic assays): The cells were then trypsinized and suspended in a hypotonic KCI solution (0.075 M) for 13 min at room temperature. After centrifugation the cells were fixed with acetic acid-methanol (1:3, v/v) and spread on clean glass slides. After air-drying, the slides were stained with Giemsa solution (1.5%, at pH 6.8; E. Merck) for 12-15 min.
- Number of cells spread and analysed per concentration (number of replicate cultures and total number of cells scored): A hundred well-spread metaphases were observed under the microscope (x 600 with a no- cover objective lens).
- Criteria for scoring chromosome aberrations (selection of analysable cells and aberration identification): The incidence of polyploid cells as well as of cells with structural chromosomal aberrations such as chromatid or chromosome gaps, breaks, exchanges, ring formations, fragmentations and others, was recorded on each culture plate. The results were considered to be negative if the incidence was less than 4.9%, equivocal if it was between 5.0 and 9.9%, and positive if it was more than 10.0%. When no reasonable dose-response relationships were found, additional experiments were carried out at similar dose levels. For a quantitative evaluation of the clastogenic potential of the positive samples, the D20 was calculated, which is the dose (mg/mL) at which structural aberrations (including gaps) were detected in 20% of the metaphases observed. In addition, the TR value was calculated, which indicates the frequency of cells with exchange-type aberrations per unit dose (mg/mL).
METHODS FOR MEASUREMENT OF CYTOTOXICITY
- Method: not reported
- Evaluation criteria:
- The results were considered to be negative if the incidence was less than 4.9%, equivocal if it was between 5.0 and 9.9%, and positive if it was more than 10.0%. When no reasonable dose-response relationships were found, additional experiments were carried out at similar dose levels. For a quantitative evaluation of the clastogenic potential of the positive samples, the D20 was calculated, which is the dose (mg/mL) at which structural aberrations (including gaps) were detected in 20% of the metaphases observed. In addition, the TR value was calculated, which indicates the frequency of cells with exchange-type aberrations per unit dose (mg/mL).
Results and discussion
Test results
- Key result
- Species / strain:
- Chinese hamster lung (CHL/IU)
- Metabolic activation:
- without
- Genotoxicity:
- negative
- Remarks:
- 0% structural aberrations and only 4% polyploidy after 48h
- Cytotoxicity / choice of top concentrations:
- no cytotoxicity
- Vehicle controls validity:
- not specified
- Untreated negative controls validity:
- not specified
- True negative controls validity:
- not examined
- Positive controls validity:
- not specified
Any other information on results incl. tables
Table 1: Results of chromosomal aberrations in vitro
Substance |
Max dose (mg/mL) |
Solvent |
Polyploid (%) |
Structural aberrations |
Result |
|
(%) |
(h) |
|||||
Oxalic acid |
10.0 |
Saline |
4 |
0.0 |
48 |
negative |
Applicant's summary and conclusion
- Conclusions:
- In the present publication of Ishidate et al. 1984 several food additives incl. Oxalic acid were evaluated for their mutagenic potential as well as in the chromosome aberration assay. CHL cells were incubated with three different concentrations of the respective food additive for 24 and 48h. Afterwards they were treated with colcemid and harvested. The cells were fixed with acetic acid-methanol, spread on glass slides and stained with Giemsa. Hundred well.spread metaphases were evaluated and considered positive if the incidence of aberrations was more than 10% and negative if the incidence was less than 4.9%. Polyploidy was found with an incidence of 4% in the highest dose tested whereas no structural aberrations were found after treatment with Oxalic acid for 48h. Thus, Oxalic acid is not considered to be a genotoxic substance under the conditions of the test.
- Executive summary:
In a mammalian cell gene mutation assay according to OECD guideline 476, Chinese hamster lung fibroblasts (V79) cultured in vitro were exposed to oxalic acid in physiological saline in different concentrations in the absence of mammalian metabolic activation (S9 mix) up to 10 mg/mL for 24 and 48 h.
The positive controls induced the appropriate response. There was no evidence of induced mutant colonies over background.
This study is classified as acceptable and satisfies the requirement for Test Guideline OECD 476 for in vitro mutagenicity (mammalian forward gene mutation) data.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.